+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Vaccines Market by Product, Animal Type, Disease Type, Route of Administration, Distribution Channel - Global Forecast 2026-2032- Product Image
Animal Vaccines Market by Product, Animal Type, Disease Type, Route of Administration, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Animal Vaccines Market by Product, Animal Type, Disease Type, Route of Administration, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5317900
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Vaccines Market is projected to reach USD 15.53 Billion in 2026. It is expected to continue growing at a CAGR of 6.99%, reaching USD 23.40 Billion by 2032.

The animal vaccines market is becoming a core pillar of veterinary public health, food security, and One Health policy. Vaccination helps reduce morbidity and mortality in livestock, poultry, aquaculture, and companion animals while lowering reliance on antimicrobials and supporting safer movement of animals and animal-derived products.

Demand is being reinforced by rising protein consumption, intensification of livestock production, expansion of pet ownership, and persistent risk from transboundary and zoonotic diseases. Verified public-health agencies such as the CDC note that six in ten known infectious diseases in people can spread from animals, while WOAH emphasizes that animal diseases cause substantial losses to global production systems. These realities keep animal vaccine development, cold-chain distribution, and disease surveillance high on the strategic agenda for veterinarians, producers, regulators, and animal health stakeholders.

Transformative Shifts in the Animal Vaccine Landscape

The animal vaccine landscape is shifting from reactive disease control toward preventive, data-led health management. Producers and veterinarians increasingly prioritize vaccination programs that protect herd and flock productivity, limit outbreak costs, support animal welfare, and improve compliance with trade, residue, and biosecurity standards.

Technology is also reshaping the competitive environment. Conventional inactivated and live attenuated vaccines remain widely used, but recombinant, vector-based, subunit, DNA, and mRNA platforms are gaining attention because they can improve antigen targeting, support differentiated immune responses, and accelerate development cycles. At the same time, regulators are placing stronger emphasis on pharmacovigilance, quality assurance, manufacturing consistency, and demonstrated field effectiveness, raising the bar for manufacturers across the animal health value chain.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the animal vaccines ecosystem by improving how pathogens are detected, antigens are prioritized, and vaccination strategies are deployed. AI-enabled bioinformatics can screen genomic and proteomic data to identify candidate antigens, support epitope mapping, assess virulence markers, and help researchers compare circulating strains with vaccine strains.

Beyond discovery, AI supports outbreak forecasting, cold-chain monitoring, manufacturing quality analytics, pharmacovigilance, and adverse-event signal detection. When integrated with veterinary diagnostics, farm management systems, geospatial data, and epidemiological databases, AI can help companies and public agencies move from calendar-based vaccination to more risk-based immunization planning. The practical impact is faster response, better targeting, stronger compliance, and improved resilience against diseases that threaten animal health and food supply.

Key Regional Insights

Asia-Pacific is a high-priority region due to its large livestock and poultry populations, expanding aquaculture sector, and continued focus on diseases affecting food animals, including avian influenza, foot-and-mouth disease, porcine diseases, and aquatic animal pathogens. China, India, Japan, South Korea, and Australia combine strong domestic demand with different regulatory and production profiles, making localized vaccine portfolios, diagnostic alignment, and distribution capability essential for market access.

North America benefits from advanced veterinary infrastructure, strong companion animal care, established livestock biosecurity programs, and broad use of diagnostics to guide preventive health planning. Europe is shaped by rigorous regulatory oversight, farm-to-fork safety priorities, antimicrobial stewardship, animal welfare standards, and high adoption of preventive veterinary medicine. Latin America, led by Brazil and Mexico, remains important for cattle, poultry, swine, and export-oriented animal protein systems, where vaccination supports productivity, trade continuity, and control of regionally significant infectious diseases.

The Middle East and Africa show rising need for vaccines that address climate-sensitive disease spread, cross-border animal movement, emerging companion animal care, and food security priorities. In these regions, affordability, heat-stable formulations, public procurement, surveillance-linked vaccination campaigns, and last-mile veterinary access are decisive factors for effective immunization coverage and sustainable disease prevention.

Key Group Insights

ASEAN demand is supported by dense poultry and swine production, aquaculture growth, and the need for scalable vaccination to protect protein supply against endemic and emerging diseases. The GCC market is more specialized, with companion animal care, equine health, camel health, and food-security investments influencing procurement, import controls, and distribution strategies across arid and high-temperature environments.

The European Union remains a benchmark for regulatory quality, traceability, antimicrobial-reduction policy, and animal welfare requirements, creating opportunities for vaccines that demonstrate safety, efficacy, consistency, and measurable value in field conditions. BRICS countries represent a broad strategic base because they combine large animal populations, expanding domestic manufacturing capabilities, public-sector disease-control priorities, and increasing emphasis on self-reliant animal health systems.

G7 markets are important for innovation, premium veterinary care, advanced companion animal medicine, and high compliance standards, while NATO countries overlap with many advanced veterinary, food-security, and biosecurity systems. Across these groups, successful companies align product registration, field evidence, pharmacovigilance, supply reliability, and local technical support with disease burdens, species economics, and policy objectives.

Key Country Insights

The United States and Canada are driven by advanced companion animal medicine, commercial livestock vaccination, strong diagnostic networks, and mature veterinary service models, while Mexico and Brazil emphasize vaccines that protect cattle, poultry, swine, and export-oriented production. Brazil’s scale in animal protein gives it strategic importance for regional disease prevention, and Mexico’s integration with North American livestock and poultry trade reinforces the value of reliable vaccination and biosecurity programs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine high veterinary standards with strong attention to antimicrobial stewardship, animal welfare, traceability, and preventive herd health. Russia’s market reflects large-scale livestock needs, transboundary disease preparedness, and domestic production priorities, making vaccine availability and local adaptation central to animal health planning.

China and India are central to global demand because of their large animal populations, protein consumption, poultry and dairy systems, and government-led disease-control programs. Japan, Australia, and South Korea add high-value opportunities through strict biosecurity, advanced veterinary services, strong disease surveillance, and premium livestock and companion animal segments where quality, safety, and regulatory compliance are essential.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize vaccine portfolios around verified disease burden, species economics, regional biosecurity gaps, and evolving One Health priorities. Investment should focus on platforms that enable faster strain updates, stronger thermostability, consistent manufacturing, and easier administration, especially for poultry, swine, cattle, aquaculture, and companion animals.

Companies should expand partnerships with diagnostic laboratories, veterinary networks, universities, producer groups, and public agencies to link vaccination with surveillance, field evidence, and outbreak preparedness. Digital traceability, AI-supported demand planning, cold-chain visibility, and post-vaccination monitoring can improve service levels and reduce waste. Leaders should also build regulatory agility by generating robust safety, efficacy, quality, and pharmacovigilance data suitable for multiple jurisdictions.

Research Methodology

This executive summary is built on secondary research from authoritative public sources, including veterinary public-health agencies, regulatory bodies, trade organizations, peer-reviewed literature, and recognized animal health institutions. Sources considered include WHO, WOAH, FAO, CDC, USDA, EMA, national veterinary authorities, and publicly available scientific and policy documents.

The analysis applies a triangulated methodology that compares disease epidemiology, species-level demand drivers, vaccination policy, regulatory trends, technology adoption, and regional market conditions. Qualitative insights are validated against observable factors such as livestock production systems, companion animal care trends, outbreak preparedness, antimicrobial stewardship initiatives, animal welfare policy, and animal health innovation activity.

Conclusion

Animal vaccines are moving from a supporting veterinary product category to a strategic tool for food security, public health, animal welfare, and sustainable animal production. The market’s long-term relevance is supported by disease prevention needs, antimicrobial stewardship, companion animal humanization, cross-border disease preparedness, and innovation in vaccine platforms.

Companies that combine scientific credibility, region-specific portfolios, reliable manufacturing, regulatory discipline, and digital intelligence will be best positioned to compete. As One Health priorities intensify, animal vaccination will remain essential for reducing disease risk, protecting animal welfare, and strengthening resilient global protein supply chains.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Vaccines Market, by Product
7.1. Inactivated Vaccines
7.2. Live Attenuated Vaccines
7.3. mRNA Vaccines
7.4. Recombinant Vaccines
7.5. Subunit Vaccines
8. Animal Vaccines Market, by Animal Type
8.1. Companion Animals
8.1.1. Cats
8.1.2. Dogs
8.2. Livestock Animals
8.2.1. Cattle
8.2.2. Poultry
8.2.3. Sheep
8.2.4. Swine
9. Animal Vaccines Market, by Disease Type
9.1. Bacterial Infections
9.1.1. Clostridial
9.1.2. E. Coli
9.1.3. Leptospirosis
9.1.4. Pasteurella
9.2. Fungal Infections
9.3. Parasitic Infections
9.3.1. Ectoparasites
9.3.2. Endoparasites
9.4. Viral Infections
9.4.1. Avian Influenza Virus
9.4.2. Bovine Viral Diarrhea Virus (BVDV)
9.4.3. Foot-and-Mouth Disease Virus (FMDV)
9.4.4. Newcastle Disease Virus
9.4.5. Porcine Reproductive & Respiratory Syndrome Virus (PRRSV)
9.4.6. Rabies Virus
10. Animal Vaccines Market, by Route of Administration
10.1. Injectable Vaccines
10.1.1. Intramuscular (IM)
10.1.2. Intravenous (IV)
10.1.3. Subcutaneous (SC)
10.2. Oral Vaccines
11. Animal Vaccines Market, by Distribution Channel
11.1. Online Pharmacies
11.2. Retail Pharmacies
11.3. Veterinary Clinics
12. Asia-Pacific Animal Vaccines Market
13. North America Animal Vaccines Market
14. Latin America Animal Vaccines Market
15. Europe Animal Vaccines Market
16. Middle East Animal Vaccines Market
17. Africa Animal Vaccines Market
18. ASEAN Animal Vaccines Market
19. GCC Animal Vaccines Market
20. European Union Animal Vaccines Market
21. BRICS Animal Vaccines Market
22. G7 Animal Vaccines Market
23. NATO Animal Vaccines Market
24. United States Animal Vaccines Market
25. Canada Animal Vaccines Market
26. Mexico Animal Vaccines Market
27. Brazil Animal Vaccines Market
28. United Kingdom Animal Vaccines Market
29. Germany Animal Vaccines Market
30. France Animal Vaccines Market
31. Russia Animal Vaccines Market
32. Italy Animal Vaccines Market
33. Spain Animal Vaccines Market
34. China Animal Vaccines Market
35. India Animal Vaccines Market
36. Japan Animal Vaccines Market
37. Australia Animal Vaccines Market
38. South Korea Animal Vaccines Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Biogénesis Bagó S.A.
40.2. BioVaxys Technology Corporation
40.3. Boehringer Ingelheim International GmbH
40.4. Brilliant Bio Pharma Private limited
40.5. Ceva Santé Animale
40.6. China Animal Husbandry Industry Co., Ltd.
40.7. Dalan Animal Health
40.8. Elanco Animal Health Inc.
40.9. Endovac Animal Health, LLC by Immvac Inc.
40.10. Hester Biosciences Limited
40.11. HIPRA, S.A.
40.12. Indian Immunologicals Limited
40.13. Kemin Industries, Inc.
40.14. Merck KGaA
40.15. Neogen Corporation
40.16. Phibro Animal Health Corporation
40.17. SAN Vet Holding GmbH
40.18. Sanofi S.A.
40.19. Seppic S.A.
40.20. Torigen Pharmaceuticals Inc.
40.21. Vaxxinova GmbH
40.22. VEROVACCiNES GmbH
40.23. Vetigenics, LLC
40.24. Vetoquinol SA
40.25. Virbac, Inc.
40.26. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL VACCINES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL VACCINES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL VACCINES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MRNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLOSTRIDIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLOSTRIDIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLOSTRIDIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL E. COLI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL E. COLI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL E. COLI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PASTEURELLA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PASTEURELLA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PASTEURELLA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ECTOPARASITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ECTOPARASITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ECTOPARASITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOPARASITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOPARASITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENDOPARASITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RABIES VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RABIES VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RABIES VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ORAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ORAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ORAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. EUROPE ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 162. EUROPE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 171. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. AFRICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 187. AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 190. AFRICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 191. AFRICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 192. AFRICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 193. AFRICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 195. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 199. ASEAN ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 200. ASEAN ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 201. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 203. ASEAN ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 204. ASEAN ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 206. ASEAN ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 207. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. GCC ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. GCC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 210. GCC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 211. GCC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 212. GCC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 213. GCC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 215. GCC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 216. GCC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 217. GCC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. GCC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 219. GCC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. BRICS ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 233. BRICS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 234. BRICS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 235. BRICS ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 236. BRICS ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 237. BRICS ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 238. BRICS ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 239. BRICS ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 240. BRICS ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 241. BRICS ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. BRICS ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 243. BRICS ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. G7 ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 245. G7 ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 246. G7 ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 248. G7 ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 249. G7 ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 250. G7 ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 251. G7 ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 252. G7 ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 253. G7 ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 254. G7 ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 255. G7 ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 256. NATO ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 257. NATO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. NATO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 259. NATO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 260. NATO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 261. NATO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 262. NATO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 263. NATO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 264. NATO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 265. NATO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 266. NATO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 267. NATO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 280. CANADA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 282. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 283. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 284. CANADA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 285. CANADA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 286. CANADA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 287. CANADA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 288. CANADA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 289. CANADA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 290. CANADA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 291. CANADA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. MEXICO ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 294. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 295. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 296. MEXICO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 297. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 298. MEXICO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 299. MEXICO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 300. MEXICO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 301. MEXICO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. MEXICO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 303. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 304. BRAZIL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 305. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 306. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 307. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 308. BRAZIL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 309. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 310. BRAZIL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 311. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 312. BRAZIL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 313. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 314. BRAZIL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 315. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 326. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 327. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 328. GERMANY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 330. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 331. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 332. GERMANY ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 333. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 334. GERMANY ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 335. GERMANY ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 336. GERMANY ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 337. GERMANY ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 338. GERMANY ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 339. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 340. FRANCE ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 341. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 342. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 343. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 344. FRANCE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 345. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 346. FRANCE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 347. FRANCE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 348. FRANCE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 349. FRANCE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 350. FRANCE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 351. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 352. RUSSIA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 353. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 354. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 355. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 356. RUSSIA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 357. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 358. RUSSIA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 359. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 360. RUSSIA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 361. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 362. RUSSIA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 363. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 364. ITALY ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 365. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 366. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION

Companies Mentioned

The companies featured in this Animal Vaccines market report include:
  • Biogénesis Bagó S.A.
  • BioVaxys Technology Corporation
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health
  • Elanco Animal Health Inc.
  • Endovac Animal Health, LLC by Immvac Inc.
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Indian Immunologicals Limited
  • Kemin Industries, Inc.
  • Merck KGaA
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • SAN Vet Holding GmbH
  • Sanofi S.A.
  • Seppic S.A.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics, LLC
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.53 Billion
Forecasted Market Value ( USD ) by 2032 $ 23.4 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Veterinary Vaccines Market by Product Type, Animal Type, Route of Administration, Valency, Storage Requirement, Disease Type, Distribution Channel - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market by Product Type, Animal Type, Route of Administration, Valency, Storage Requirement, Disease Type, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Veterinary/Animal Vaccines Market by Product Type, Route of Administration, Disease Indication, Technology Platform, Valency, Animal Type, Distribution Channel, End User - Global Forecast 2026-2032 - Product Image

Veterinary/Animal Vaccines Market by Product Type, Route of Administration, Disease Indication, Technology Platform, Valency, Animal Type, Distribution Channel, End User - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Animal Vaccines Market Size, Share & Trends Analysis Report by Product, Animal, Route of Administration, Distribution Channel, Region, and Growth Forecasts, 2026-2033 - Product Image

Animal Vaccines Market Size, Share & Trends Analysis Report by Product, Animal, Route of Administration, Distribution Channel, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Companion Animal Vaccines - Global Strategic Business Report - Product Image

Companion Animal Vaccines - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Animal Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Animal Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 142 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.